conditional PTEN-deficient mice into the PI3K␥-defi-
Signaling through GPCRs and PI3K␥ is considered to Together, these results unveil PI3K␥ as a multifunctional protein capable of relaying, in heart, both kinase activitybe involved in the pathogenesis of cardiac hypertrophy and heart failure. Indeed, PI3K␥ activity is increased dependent and -independent signaling events. in hearts of mice subjected to pressure overload by transverse aortic constriction (TAC) (Naga Prasad et al., Figure 1E ). As in PI3K␥ Ϫ/Ϫ con-( Figure 2F ). This was unexpected, as it had been previously reported that the lack of PI3K␥ caused reduced trols, PI3K␥ KD/KD macrophages showed a significantly reduced chemotactic response to these GPCR agonists macrophage migration in response to a wide range of chemotactic stimuli (Hirsch et al., 2000) . However, inbut not to PMA ( Figure 1F) . Furthermore, in a model of E. coli-induced septic peritonitis, peritoneal recruitment flammatory cells (but not cardiomyocytes) stained positive for phosphorylated PKB/Akt, thus suggesting the of PI3K␥ KD/KD neutrophils and macrophages was as dramatically reduced ( Figure 1G ) as in PI3K␥
Results 2000). PI3K␥ also plays a role in the effects of chronic ␤-adrenergic (A␤) receptor stimulation detected in the
Ϫ/Ϫ controls activation of a PI3K␥-independent recruitment mechanism ( Figure 2F Anatomical inspection of hearts subjected to a presshowed the presence of the necrotic lesions detected in similarly treated PI3K␥-deficient mice. Furthermore, sure gradient higher than 40 mm Hg for 7 days revealed a multifocal myocardial damage in PI3K␥ Ϫ/Ϫ samples extracellular matrix deposition was dramatically reduced in the PI3K␥ KD/KD genetic background (Figures 3E that was absent in controls ( Figure 2D ). Histological analysis of the lesions showed regions of massive carand 3F). In addition, immunostaining of pressure-overloaded PI3K␥ KD/KD hearts with anti-CD18 and anti-F4/ diomyocyte loss and fibrotic substitution ( Figure 2E ). Detection of extracellular matrix deposition evidenced 80 antibodies did not reveal any significant leukocyte infiltration ( Figure 3E ). On the other hand, detection of a dispersed pattern in wild-type cardiac samples but a predominant distribution around the necrotic regions in activated PKB/Akt evidenced a marked reduction in immunoreactivity throughout the ventricle wall. As a whole, mutant hearts. In PI3K␥ Ϫ/Ϫ mice, the left ventricle mass was not reduced in comparison to that of wild-type mice these results indicate that the expression of kinase-dead PI3K␥ results in a cardiac response to TAC different (data not shown), but the mean cardiomyocyte crosssectional area was smaller than controls (sham: 79.5 Ϯ from that caused by either the absence of the protein or the presence of its wild-type form. 1.8, 7 days TAC: 183.9 Ϯ 2.5 m 2 for PI3K␥ ϩ/ϩ left ventri- KD/KD showed an equal increase in PKB/Akt, Erk1/2, and p38 phosphoryevaluated in all three genotypes. Interestingly, baseline cAMP concentration in hearts of sham-operated lation over the levels of sham-operated mice (data not shown). Intriguingly, however, the analysis performed PI3K␥ Ϫ/Ϫ mice was significantly higher than that of wildtype and PI3K␥ KD/KD controls, which instead showed 5 hr after TAC showed that, while in wild-type left ventricles, phosphorylation of PKB/Akt, Erk1/2, and p38 reidentical cAMP levels ( Figure 5A ). Ten minutes of TAC generated no significant variation in cAMP levels of all mained elevated over sham-operated controls, in PI3K␥ Ϫ/Ϫ and PI3K␥ KD/KD cardiac extracts, activation of three genotypes ( Figure 5A ). By contrast, 5 hr after TAC, PI3K␥ ϩ/ϩ , PI3K␥ Ϫ/Ϫ , and PI3K␥ KD/KD hearts showed a sigthe three kinases was significantly blunted (Figures 4A- of cardiac PLN was stronger in PI3K␥ Ϫ/Ϫ sham-operated mice than in wild-type and PI3K␥ KD/KD controls ( Figure  5B) . Moreover, phosphorylation of phospholamban 5 hr after TAC was low in PI3K␥ ϩ/ϩ and PI3K␥ KD/KD cardiac extracts but was significantly increased in hearts lacking PI3K␥ ( Figure 5B) . Altogether, these data show that PI3K␥ controls cardiac cAMP levels independently of its kinase activity.
To determine whether, in PI3K␥ Ϫ/Ϫ hearts, the alteration of cAMP level played a role in the development of TAC-induced myocardial injury, mice were treated intraperitoneally with the nonselective ␤ blocker propranolol, a drug well-recognized to lower cAMP levels. Measurement of cAMP at 5 hr after TAC in mice treated with propranolol immediately after surgery showed that, in hearts lacking PI3K␥, the drug significantly reduced the cAMP increase following aortic banding ( Figure 5C ). To analyze the long-term effects of propranolol on PI3K␥ Ϫ/Ϫ hearts subjected to pressure overload, mice were repeatedly treated with this drug over 7 days (15 mg/kg per day). Remarkably, this treatment blocked the formation of the necrotic lesions in left ventricles subjected to pressure gradients above 40 mm Hg. Accordingly, echocardiographic analysis revealed that, in conditions of chronic pressure overload, propranolol protected PI3K␥ Ϫ/Ϫ mice from a rapid progression to heart failure and allowed the onset of a concentric hypertrophic remodeling ( Figure 5D , Tables 1 
and 2). Shamoperated and banded PI3K␥
Ϫ/Ϫ mice treated with propranolol still showed a slightly increased myocardial contractility compared to treated wild-type controls ( Figure 5D , Table 2 ), suggesting that cAMP concentration was reduced by propranolol below the critical threshold for myocardial injury but that it was still high enough to maintain a positive effect on cardiac contractility. Nevertheless, histological analysis 7 days after TAC of propranolol-treated PI3K␥ Ϫ/Ϫ hearts showed a reduction in the fibrotic reaction identical to that observed in PI3K␥ KD/KD cardiac samples ( Figure 5E ). Overall, these data indicate that the aberrant elevation of cAMP caused by lack of PI3K␥ is responsible for the TACinduced heart failure in PI3K␥ Ϫ/Ϫ mice. strong elevation of cAMP levels ( Figure 6A ), thus suggesting that, in PI3K␥ Ϫ/Ϫ hearts, an aberrantly decreased activity of G i was not responsible for the elevated cAMP levels. On the other hand, cAMP concentration depends nificant increase in cAMP concentration over shamoperated controls. However, the elevation of cAMP levon the balance between its production and its degradation by cyclic nucleotide phosphodiesterases. The conels observed in PI3K␥ Ϫ/Ϫ hearts was dramatically higher than that measured in PI3K␥ ϩ/ϩ and PI3K␥ KD/KD hearts, centration of cAMP in hearts from mice of the three genotypes was thus measured after treatment with the which showed equivalent values. In the heart, increased cAMP causes activation of PKA, which phosphorylates nonselective phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX). In this condition, cAMP in wildphospholamban (PLN) in the sarcoplasmic reticulum. Consistent with cAMP measurements, phosphorylation type and PI3K␥ KD/KD samples reached a level similar to that of PI3K␥ Ϫ/Ϫ hearts ( Figure 6B ), strongly suggesting tion. We thus investigated whether a phosphodiesterase (PDE) activity could associate to PI3K␥. Using an in vitro an impaired regulation of phosphodiesterase activity in PI3K␥ Ϫ/Ϫ hearts. assay, PDE activity was measured in PI3K␥ immunoprecipitates from PI3K␥ ϩ/ϩ total heart extracts. Strikingly, The normal cAMP levels in PI3K␥ KD/KD hearts indicated that cAMP concentration was not dependent on PI3K␥ this method revealed that PI3K␥ could coimmunoprecipitate with a PDE enzymatic activity that specifically kinase activity but possibly on protein/protein interac- KD/KD versus PI3K␥ ϩ/ϩ n.s.; n ϭ 3). On the that a PDE was unspecifically recognized by the anti-PI3K␥ antibody, the assay was repeated using the immuother hand, the addition of the PDE inhibitor IBMX to PI3K␥ immunoprecipitates decreased the PDE activity noprecipitate of extracts derived from PI3K␥ Ϫ/Ϫ hearts. In this case, no relevant PDE activity was observed (Figto background levels (Figure 6D ), thus indicating that, in cardiac tissue, PI3K␥ indeed associates with a PDE. ure 6C). PI3K␥ association with the PDE activity appeared constitutive and not susceptible to A␤ modulaTo determine which type of PDE activity was involved in this association, different class-specific PDE inhibition: identical enzymatic activities could be retrieved from hearts in basal conditions as well as from hearts tors were tested ( Figure 6E) , and only enoximone, a class 3 PDE inhibitor, significantly reduced the PDE activity treated with isoproterenol prior to homogenization. To test whether PI3K␥ itself could degrade cAMP, the PDE observed in immunoprecipitates, thus indicating that cardiac PI3K␥ is associated with PDE3 ( Figure 6E ). enzymatic assay was performed with recombinant human PI3K␥, but no activity could be detected (data not To date, two different PDE3 isoforms, PDE3A and PDE3B, have been described (Movsesian, 2002) . Westshown). Consistently, a PDE activity was immunoprecip-ern blot analysis revealed that these two isoforms were after aortic banding, the kinase activity of PI3K␥ is required for the sustained phosphorylation of PKB/Akt as equally expressed in hearts of all three genotypes (Figwell (Figure 6F ), PDE3B readily coimmunoprocess on PtdIns(3,4,5)P 3 production. In the heart, precipitated with PI3K␥ from both wild-type and PI3K␥ KD PKB/Akt activation protects from apoptosis but also heart extracts ( Figure 6E) . influences cell size. For example, reduction of PKB/Akt To test whether the association with PI3K␥ controls activation by a kinase-dead PI3K␣ reduces cardiac size the catalytic activity of PDE3B, this phosphodiesterase (Shioi et al., 2000) . Furthermore, transgenic mice exwas immunoprecipitated from hearts of the three genopressing a constitutively active PKB/Akt in the heart types, and PDE activity in the pellet was analyzed. As spontaneously develop cardiac hypertrophy and dilatashown in Figure 6H The finding that the kinase activity of PI3K␥ was rerecombinant PI3K␥ to the PDE3B immunoprecipitates quired for TAC-triggered signaling events did not explain did not show a significant rescue of PDE activity (Figure the different phenotypic responses to pressure overload 6I), thus indicating that a direct interaction between the detected in PI3K␥ Ϫ/Ϫ and PI3K␥ KD/KD hearts. Protection two proteins is not sufficient to drive PDE3B activation from the development of necrotic lesions and fibrosis and that other molecular partners are needed. Overall, observed in PI3K␥ KD/KD hearts strongly suggests that these data demonstrate that PI3K␥ is a crucial element PI3K␥ is involved in signaling processes unrelated to its of a multimolecular complex controlling PDE3B function kinase activity. A possible explanation for this difference in the intact heart. could reside in the distinct amounts of cAMP found in hearts of the two genotypes. In the heart, cAMP producDiscussion tion is triggered by G ␣s -coupled receptors, such as the ␤ 1 -adrenergic receptor, which cause the activation of To model the effects of catalytic activity inhibition of adenylate cyclase. Abnormal activation of the signaling PI3K␥, we generated a mouse expressing a kinase-dead cascade involving cAMP elevation in heart is known to PI3K␥ and found that the phenotype of PI3K␥ ponent. Further studies are now needed to define the All transgenic mouse strains with an increased A␤ nature of the proteins involved in this process. drive show slowly progressive myocardial degeneration Taken together, our data indicate that, in the pressureand fibrosis. However, none develop lesions with the overloaded left ventricle, PI3K␥ plays a dual role: first, rapidity (they usually appear after weeks) and the extent through its kinase activity, it controls MAPK and Akt (they are normally evident only by histological examinaactivation, which possibly induce fibrosis and hypertrotion) detected in aortic-banded PI3K␥ Ϫ/Ϫ mice. This obphy, respectively; second, via association with PDE3B, it servation suggests that when an enhanced cAMP proinduces cAMP level reduction and eventually negatively duction is coupled to a strong left ventricular mechanical modulates cardiac contractility. overload, the myocardial degeneration is accelerated and intensified. In possible agreement with such a
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